Category Archives: Bad Drugs
Risperdal Judge Explains Reasons for Denying Janssen a New Trial
A recent plaintiff verdict overturned, the Pennsylvania state judge assigned to the case explained last month why he denied a request by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. for a new trial in the Risperdal side effects …
— Experts.com (@Experts_Com) September 19, 2017
Philadelphia Risperdal Docket Almost Triples in First Half of 2017
The number of cases involving the anti-psychotic drug Risperdal almost tripled in the first half of 2017, jumping from approximately 2,000 cases at the beginning of the year to more than 5,500 as of June 2017, comprising the largest mass tort …
Risperdal Plaintiff Green Lighted to Pursue Risperdal Lawsuit in New York
New York, NY
The plaintiff in a Risperdal lawsuit who faced a petition for summary judgement on the part of the manufacturer, won the right to pursue the majority of his claims following a ruling by a New York judge that testimony by an expert witness …
Risperdal Lawsuit Filings Exceed 6000 in Pennsylvania Mass Tort, as Court Prepares for Sept Meeting
Plaintiffs who allegedly developed gynecomastia due to treatment with Risperdal continue to file claims in the Pennsylvania mass tort program currently underway in the Philadelphia Court of Common Pleas.
Philadelphia Judge Refuses to Overturn $2.5 Million Risperdal Plaintiff Verdict
According to testimony given by Pledger’s mother during the trial in the family’s Risperdal lawsuit. Benita Pledger also testified that her son would habitually cover himself with a large towel when he stepped from the shower, before he could bring …
Second Bellwether Xarelto Lawsuit Goes to Defendant, All Eyes on Third
New Orleans, LA
The second bellwether Xarelto lawsuit in multidistrict litigation over allegations of Xarelto bleed-out in association with the new age blood thinner has gone, like the first, to the defendant.
While this may prove disappointing to …
— Top Class Actions (@TopClassActions) July 27, 2017
Johnson & Johnson, Bayer score a second key win in Xarelto bleeding litigation
Johnson & Johnson and Bayer are two-for-two in defending Xarelto against liability lawsuits.
The drugmakers aren’t in the clear yet, though, with another bellwether trial set for August and thousands of additional suits claim the blockbuster blood …
Bayer, Janssen Win 2nd Xarelto Bellwether Trial
A New Orleans federal jury on Monday awarded a defense verdict to Janssen and Bayer in the second bellwether trial in multidistrict litigation over unstoppable bleeding allegedly caused by their blood …
J&J, Bayer Cleared of Responsibility at Xarelto Trial
Johnson & Johnson and Bayer AG aren’t responsible for a Xarelto user’s internal bleeding, a jury found in the first trial over the blood-thinning drug.
J&J and Bayer didn’t mislead a Louisiana man and his doctors about the blood-thinning drug’s health …
Risperdal Lawsuit Hits 18,000 and Climbing
The Risperdal lawsuit count now stands at a number above 18,000.
To that end a staggering number of cases name pharmaceutical giants Johnson & Johnson (J&J) and subsidiary Janssen Pharmaceuticals as defendants.
Most allege …
— Top Class Actions (@TopClassActions) June 30, 2017
Parties to Pennsylvania Risperdal Gynecomastia Lawsuits Set to Meet Next Month to Discuss Status of Mass Tort
Thousands of Risperdal lawsuits involving the antipsychotic medication’s alleged potential to cause gynecomastia (male breast growth) continue to move forward in a mass tort litigation now underway in …
Johnson & Johnson’s Action Spikes Risperdal Cases Filed in PA Court
Risperdal lawsuits are highly sensitive because the plaintiffs involved here are psychologically compromised young boys.
Risperdal (risperidone) is an antipsychotic medication that is believed to have caused mental and physical trauma and torture to …
— Top Class Actions (@TopClassActions) June 28, 2017
“Risperdal Boys” Photo Project Vividly Captures Pain of Gynecomastia
Thousands of Risperdal lawsuits have been filed in U.S. courts on behalf of men and boys who allegedly developed gynecomastia due to treatment with the antipsychotic drug.
Now a new photography project is vividly capturing the suffering endured by …
Seeking Help Is Difficult for Bipolar Man with Risperdal “Man Boobs”
Most of us don’t think twice to talk with our doctor if we think there is an issue—a side effect—associated with a prescribed medication.
But many people with mental illness don’t have the wherewithal to seek help.
Such was the case …
Lawsuit Targets Missouri Over Psychotropic Drug Use Among Foster Care Children
A new lawsuit has been filed in Missouri on behalf of foster care children who were allegedly prescribed Risperdal and other psychotropic drugs inappropriately.
The child advocates behind the lawsuit want the state to implement systemic changes that …
‘Chemical straight-jackets:’ Lawsuit claims Missouri foster kids prescribed too many meds
The five plaintiffs, identified by their initials, include two- and three-year-old sisters who were allegedly prescribed Risperdal, an antipsychotic not approved by the Food and Drug Administration for children under five.
Another plaintiff, aged 12 …
Missouri Sued Over Psychotropic Drugs for Foster Care Kids
JEFFERSON CITY, Mo.
Child advocates filed a federal lawsuit against the Missouri Department of Social Services on Monday over allegations of inappropriately providing psychotropic drugs to foster care children and systemic lack of oversight of …
More details here
Janssen Pharmaceuticals granted nonsuit motion in latest Philadelphia Risperdal lawsuit
The latest Risperdal lawsuit to go to trial here has been dismissed by a state court judge for a piece of photographic evidence allegedly lacking authentication, marking the fifth courtroom victory for the drug’s manufacturer, Janssen …
J&J Faces 3000 More Risperdal Gynecomastia Lawsuits
An additional 3,000 plaintiffs filed Risperdal (risperidone) gynecomastia lawsuits against Johnson & Johnson and Janssen Pharmaceuticals in 2017, bringing the total to more than 5,500, Forbes reported.
According to reports from the Philadelphia Court …
Xarelto manufacturers win jury verdict in first federal bellwether trial on drug’s potential risk liability
The group of more than 18,000 Xarelto lawsuits have been consolidated through the federal court system’s multi-district litigation (MDL) process.
This process utilizes bellwether trials to establish evidence and determine any settlement value for similar …
— Riya Verma (@RiyaSuper) May 6, 2017
First Xarelto Bellwether Trial Ends In Defense Verdict
According to Fierce Pharma, Joseph Boudreaux was the first patient to file a Xarelto lawsuit in the United States.
His claim is now joined by around 18,000 other lawsuits, many of which have been consolidated in the US District Court for the Eastern …
— Alex Jones (@RealAlexJones) April 27, 2017
First Xarelto federal bellwether trial beginning in Louisiana
The initial bellwether trial to ascertain whether the manufacturers of Xarelto are liable for claims which allege the blood-thinning medication caused injury or death to more than 15,000 patients was slated to begin Monday in Louisiana …
Fresenius slips 1st Naturalyte bellwether trial
Fresenius Medical Care (NYSE:FMS) last week won the 1st bellwether trial in a series of product liability lawsuits brought over its GranuFlo and NaturaLyte dialysis drugs, after a Massachusetts jury found that the plaintiff’s estate failed to prove its …
Beshear sues nation’s largest kidney dialysis provider
Beshear claimed in the suit filed in Franklin Circuit Court that Fresenius, headquartered in Waltham, Mass., promoted its kidney dialysis product, GranuFlo, as safe despite clinical trials finding it harmful.
The lawsuit seeks to recover damages and …
Lawsuit claims DaVita hid harmful effects of dialysis solution that caused heart attacks
The lawsuit says that since at least 2004, DaVita used a dialysis solution called GranuFlo that caused complications including heart attacks and strokes.
On Nov. 4, 2011, an internal study by Fresenius Medical Care, the maker of GranuFlo, resulted in a …
$250 Million Settlement Reached in Granuflo Litigation
Fresenius Medical Care, one of the largest providers of dialysis products in the world, has agreed to set aside $250 million to settle more than 10,000 lawsuits filed by dialysis patients and family members.
The plaintiffs in those lawsuits allege use …
Fresenius pays $250M to settle GranuFlo/NaturaLyte lawsuits
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) agrees to pay $250M to resolve U.S. litigation related to its GranuFlo and NaturaLyte products.
Under the terms of the agreement, 97% of the plaintiffs must agree to the settlement by July to receive …
First Xarelto federal bellwether trial beginning in Louisiana
Philadelphia’s Complex Litigation Center is also expected to see its first trial this year.
Plaintiffs charge Xarelto manufacturers with failing to properly warn patients that Xarelto use presented increased risks for cranial and gastrointestinal …
— Max Mitchell (@MMitchellTLI) April 26, 2017
J&J, Bayer Accused of Hiding Xarelto Dangers in First Trial
Joseph Boudreaux took Xarelto to help cut his stroke risk, but instead the drug caused serious gastrointestinal bleeding, according to his lawsuit.
Boudreaux spent a week in the intensive care unit and needed several blood transfusions and heart …
J&J, Bayer Accused of Hiding Blood-Thinning Drug’s Flaws
Joseph Boudreaux says taking Johnson & Johnson’s blood-thinning drug Xarelto was one of the biggest mistakes of his life.
While Xarelto was supposed to help cut his stroke risk, Boudreaux says it instead caused internal bleeding that required a week …
First Xarelto Case to Test Views Over Attorney Ads
House Judiciary Committee Chairman Bob Goodlatte, who co-authored a tort reform bill that the U.S. House of Representatives passed last month, referenced the Xarelto litigation in letters last month calling on the American Bar Association and various …
Pharmaceutical companies seeking to ascertain if third-party funding in Xarelto litigation
In their motion, Xarelto manufacturers asked if any third-party “has the right to control or be consulted about the plaintiffs’ litigation and whether there is a third-party source of funding for the plaintiffs’ litigation”, in addition to seeking the …
Xarelto Makers Want Plaintiffs' Litigation Funding Info https://t.co/bhaJvAIx0v
— Mass Tort Journal (@MassTortJournal) April 18, 2017
Defendants on Philadelphia Xarelto Mass Tort Seek Disclosure of Third-Party Funding
As the Philadelphia Xarelto mass tort moves closer towards the bellwether trial stage, Xarelto principles Bayer AG and Janssen Pharmaceuticals have signaled that they want to know the identity of any third-party funders associated with …
FDA Sends Warning Letters Over Xarelto TV Commercials
The companies would be wise to heed the FDA’s warning.
False or misleading advertisements have played a large role in several pharmaceutical litigations, including Janssen Pharmaceutical’s Xarelto lawsuits and GlaxoSmithKline’s Zofran lawsuits.
Janssen and J&J Facing Over 15000 Xarelto Lawsuits
A multidistrict litigation in Louisiana houses over 14,400 Xarelto lawsuits filed against J&J and its subsidiary, Janssen Pharmaceuticals.
Another 1,000 lawsuits are currently pending in a mass tort program in Pennsylvania.
The first bellwether trials …
'Joseph Boudreaux will be the first plaintiff to have his trial go forward.' https://t.co/cWMxllBWPW
— TheGoldwaterLawFirm (@GoldwaterLaw) January 11, 2017
Xarelto Bleeding Complication Lawsuits Increasing – Legal Examiner
The wave of litigation stemming from Xarelto bleeding complications continues to grow. There are now almost 7,000 pending lawsuits, including 2,800 federal cases that have been consolidated into multidistrict litigation and being overseen by the …
Woman’s lawsuit vs Bayer AG, others adds to litigation over Xarelto
According to the complaint, the plaintiff alleges that she suffered severe physical injuries as the result of ingesting Xarelto.
The plaintiff holds the defendants responsible for allegedly manufacturing and distributing defective products.
Janssen Faces Over 15000 Xarelto Bleeding Lawsuits
There are now more than 1,000 lawsuits pending in a “mass-tort” at the state level in the Philadelphia Court of Common Pleas.
As of December 15, another 14,465 Xarelto lawsuits were pending in a federal Multi-District Litigation (MDL No. 2592) in …
Eli Lilly Defeats “Bellwether” Cymbalta Withdrawal Lawsuit
There is always a call to check and limit insanity that harms and the growing recognition of the deceits and coercions of systemic and institutional corruption, will not cease as a result of not ‘winning’ a particular lawsuit.
Wouldn’t you look at it …
@victonult omg really. Seek Help. Cymbalta can help
— Tyra (@seungshine_) December 23, 2016
Lilly faces first trial over claims of Cymbalta withdrawal symptoms
Earlier this year, a U.S. judge dealt Eli Lilly a stinging blow after refusing to toss out lawsuits claiming that the company downplayed withdrawal symptoms linked to its blockbuster antidepressant, Cymbalta.
Now Lilly is facing the first U.S …
Will pain reliever lead to heart attacks?
Q. Just how hard it would it be to come off Cymbalta?
I have constant “brain zaps” and ringing in my ears.
Symptoms of Cymbalta discontinuation syndrome can be severe
A: Duloxetine (Cymbalta) is prescribed for anxiety, depression and pain.
The Food and Drug Administration acknowledged a “Cymbalta discontinuation syndrome” in 2009.
Unfortunately, symptoms such as severe mood swings, brain zaps and neurological …
People’s Pharmacy: Be careful when weaning off Cymbalta
No one ever told me just how hard it would be to come off Cymbalta.
I have constant “brain zaps” and ringing in my ears.
I get angry and break out in fits, yelling then crying.
Sunlight hurts my eyes, and loud noise makes me crazy.
I’m dog-tired, with …
Lilly chalks up a win for Cymbalta in first U.S. trial over withdrawal symptom claims
But in June, U.S. District Judge Stephen Wilson shrugged off Lilly’s attempts to throw out lawsuits over Cymbalta, ruling that patients raised some important questions about how the company portrayed withdrawal side effects.
Lilly is set to face the …
Is This Lipitor Litigation’s Last Gasp?
Pfizer may have got a lucky break in the Lipitor multidistrict litigation (MDL).
The popular statin drug used to treat high cholesterol has been linked to the development of type-2 diabetes.
Based on a recent judicial order, the Lipitor MDL plaintiffs …
Beyond Lipitor Type 2 Diabetes, a New Concern with Statins
Among the ongoing concerns over the statin Lipitor are the potential for type 2 diabetes and cognitive issues such as memory and concentration.
Atorvastatin (Lipitor) type 2 diabetes remains one of the biggest frustrations alleged in …
Former Pfizer employee loses another bid to press illegal marketing lawsuit
A federal appeals court last week refused 1 to revive a lawsuit in which a former Pfizer employee alleged the company promoted off-label use of its Lipitor cholesterol pill.
In doing so, however, the court also raised a question about the extent to …
Over 2400 Lipitor Diabetes Lawsuits Filed in Federal Court, More Expected
Lawsuits against Pfizer alleging that its blockbuster cholesterol drug Lipitor (atorvastatin) – a statin taken by millions of Americans – caused Type 2 diabetes continue to mount, as the first bellwether cases in federal multidistrict litigation (MDL …
Pfizer Wins Lipitor Lawsuit in Australia
Melbourne, Australia Pfizer may have lost its motion to dismiss in Lipitor lawsuits in the US, but the drugmaker is celebrating a victory in Australia.
An Australian consumer watchdog filed a Lipitor lawsuit against Pfizer, alleging the company engaged …
Pfizer’s Attempt to Toss Lawsuits in Lipitor Diabetes Lawsuits MDL Rejected
Charleston, SC The manufacturer of Lipitor recently attempted to cast off 10 atorvastatin type 2 diabetes cases in the Lipitor Diabetes Lawsuits MDL on grounds that failure-to-warn claims made by the plaintiffs were preempted by federal regulation …
Pfizer Can’t Duck 10 Lipitor Diabetes Claims
A South Carolina federal judge on Monday nixed Pfizer Inc.’s attempt to duck 10 cases in multidistrict litigation over claims that its cholesterol drug Lipitor can cause diabetes, saying that their …
Lipitor Lawsuits Climbing but Pfizer Digging In
New York, NY As the number of cases in the Lipitor Diabetes Lawsuits MDL continue to spike, Lipitor manufacturer Pfizer Inc. continues to position itself following the expiration of its patent in November 2011. One of those moves, as evidenced by a …
Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor
(Pfizer Inc and India’s Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug Lipitor. U.S. District Judge Peter Sheridan in …
Ask the pharmacists: Are new blood thinners right for me?
So patients using this medicine were excited to learn that at least four new agents to reduce blood clotting — without the need for frequent blood testing — were introduced in the U.S.
Drug Combo for Irregular Heartbeat Might Raise Bleeding Risk
A new Canadian study suggests that combining one blood thinner, Pradaxa, with certain statin medications could raise the odds for bleeding in these patients.
“An increase in the risk of bleeding requiring hospital admission or emergency department …
What you need to know about risky blood thinners
The study in CMAJ – by researchers in Toronto – looked at nearly 46,000 patients in Ontario age 65 and older who take a blood thinner called dabigatran etexilate – sold under the brand name Pradaxa.
Between 2012 and 2014, 1,117 of the patients suffered …
Manufacturer Tries to Evade Pradaxa Wrongful Death Lawsuit
Having already paid out $650 million to settle lawsuits in 2014, attorneys for the makers of dabigatran Pradaxa are busy attempting to escape a wrongful death lawsuit scheduled for December.
It would be the first federal …
New2Trip: Anticoagulant: "antidote" to dabigatran (Pradaxa) is insufficiently evaluated https://t.co/A1yP92CkCn
— Trip Primary Care (@TripPrimaryCare) December 10, 2016
Xarelto may cause more serious bleeding than Pradaxa
The novel oral anticoagulant (NOAC) field is hotly contested, and drugmakers are turning to real-world data to gain their meds an advantage.
Now, Boehringer Ingelheim may have one such advantage for its Pradaxa (dabigatran) over market leader Xarelto …